Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
Aim. Continuous subcutaneous insulin infusion (CSII) is used as an option in patients with diabetes failing to multiple daily injections (MDI). Psychological factors may play a relevant role in the failure to attain therapeutic goals in patients on MDI. This could lead to an overrepresentation of ps...
Saved in:
Main Authors: | Francesco Rotella, Caterina Lamanna, Ilaria Dicembrini, Carlo Faravelli, Caterina Calasso, Edoardo Mannucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2013/672729 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-Term Effect of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection in Perioperative Patients with Type 2 Diabetes Mellitus
by: Wei Song, et al.
Published: (2023-01-01) -
Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes
by: Yuting Ruan, et al.
Published: (2021-01-01) -
A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes
by: Shuo Lin, et al.
Published: (2018-01-01) -
Treatment of Severe Hypertriglyceridemia with Continuous Insulin Infusion
by: Yesica Rodríguez Santana, et al.
Published: (2011-01-01) -
Performance of a Continuous Subcutaneous Insulin Infusion (CSII) Pump With Acoustic Volume and Flow Sensing in Simulated High-Consequence Situations
by: Robert D. Butterfield, et al.
Published: (2024-01-01)